Drug interactions with carbamazepine oral and elvitegr-cobicist-emtric-tenof oral

carbamazepine oral brand names and other generic formulations include:

Atretol Oral, Carbatrol Oral, Epitol Oral, Equetro Oral, Tegretol Oral, Tegretol XR Oral

All generic drug interactions for carbamazepine oral (lists will include brand and generic names):

elvitegr-cobicist-emtric-tenof oral brand names and other generic formulations include:

Stribild Oral

All generic drug interactions for elvitegr-cobicist-emtric-tenof oral (lists will include brand and generic names):
ContraindicatedNever use this combination of drugs because of high risk for dangerous interaction

carbamazepine oral and elvitegr-cobicist-emtric-tenof oral

carbamazepine oral decreases levels of elvitegr-cobicist-emtric-tenof oral by altering drug metabolism. Antiviral effects may decrease.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
ContraindicatedNever use combination.

carbamazepine oral and elvitegr-cobicist-emtric-tenof oral

carbamazepine oral decreases levels of elvitegr-cobicist-emtric-tenof oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. May lead to loss of virologic response and possible resistance

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.
ContraindicatedPotential for significant interaction (monitoring by your doctor is likely required)

elvitegr-cobicist-emtric-tenof oral and carbamazepine oral

elvitegr-cobicist-emtric-tenof oral increases levels of carbamazepine oral by altering drug metabolism. Cobicistat may increase blood levels and side effects of the other drug including serious and/or life-threatening events.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
ContraindicatedPotential for dangerous interaction. Use with caution and monitor closely.

elvitegr-cobicist-emtric-tenof oral and carbamazepine oral

elvitegr-cobicist-emtric-tenof oral increases levels of carbamazepine oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Cobicistat is a CYP3A4 inhibitor; contraindicated with CYP3A4 substrates for which elevated plasma concentrations are associated with serious and/or life-threatening events

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.

Check for more interactions with the Drug Interaction Checker

Drug Interaction Categories

Contraindicated

Never use this combination of drugs because of high risk for dangerous interaction

Serious

Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

Significant

Potential for significant interaction (monitoring by your doctor is likely required)

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD